Immediate Impact
62 standout
Citing Papers
Current insights and future perspectives of ultraviolet radiation (UV) exposure: Friends and foes to the skin and beyond the skin
2024 Standout
Cutaneous melanoma
2023 Standout
Works of N. Eggmann being referenced
Vemurafenib in patients with BRAFV600 mutation-positive melanoma with symptomatic brain metastases: Final results of an open-label pilot study
2013
Open-Label Pilot Study of Vemurafenib in Previously Treated Metastatic Melanoma (MM) Patients (PTS) with Symptomatic Brain Metastases (BM)
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| N. Eggmann | 191 | 190 | 50 | 153 | 8 | 328 | |
| Lea Felderer | 183 | 260 | 44 | 151 | 6 | 352 | |
| Lydia Giles | 219 | 208 | 28 | 63 | 10 | 339 | |
| Comis Rl | 189 | 154 | 22 | 60 | 11 | 339 | |
| J. P. Bizzari | 228 | 173 | 12 | 116 | 10 | 339 | |
| Hui Qin Wang | 118 | 149 | 28 | 67 | 11 | 284 | |
| Robert L. Ruxer | 174 | 158 | 8 | 127 | 13 | 344 | |
| Patrizia Maddalena | 92 | 140 | 40 | 26 | 14 | 266 | |
| Margherita Carucci | 159 | 129 | 6 | 189 | 7 | 286 | |
| Diederik van Bodegom | 97 | 179 | 30 | 19 | 10 | 350 | |
| Akihisa Kiyota | 239 | 158 | 13 | 72 | 11 | 352 |
All Works
Loading papers...